Solihull-LOC

[Solihull-LOC @Solihull_LOC]

Pop the date into your diaries! 😆

[@OptometryToday @OptometryToday]

Scope Connect is a dynamic digital platform designed to empower eye care professionals with trusted insights, practical diagnostic tools, and patient support resources.

Learn more about the platform here ➡️ https://t.co/txgZmgoRpj

[@OptometryToday @OptometryToday]

Scope Eyecare’s IP bursary has returned for its 5th year. The company offers £3000 to a UK-registered optometrist planning to undertake an IP qualification.

Applications but be submitted before the closing date of 31 May.

Find out more 👉 https://t.co/zDuVRifWjB

[Glaucoma Today @GlaucomaToday]

In this episode, Roya Garakani, DO, and Mahsaw Mansoor, MD, share their insights into surgical management of uveitis-glaucoma-hyphema syndrome, as featured in the January/February 2026 issue of Glaucoma Today.

Listen more here: https://t.co/rM4SYLgFo9

[Solihull-LOC @Solihull_LOC]

OT speaks with associate professor, Dr Anthony St. Leger, about a naturally occurring microbe that can be engineered to promote corneal healing

https://t.co/gmeq5AlQCm

[Solihull-LOC @Solihull_LOC]

Save the date in your diaries

[@OptometryToday @OptometryToday]

The AOP is urging members in England to let their MPs know about a parliamentary drop-in event taking place next week. @The_AOP shared that members asking their MP to attend can make a huge difference.

Interested? Get involved and learn more 👉 https://t.co/tlHdgE9JhU

[@OptometryToday @OptometryToday]

UK researchers have highlighted that long-term use of topical anti-glaucoma medication is associated with an adverse effect on SLT outcomes.

Read more about the research here: https://t.co/UasGzjtp9L

[@OptometryToday @OptometryToday]

Deafblind Scotland and @DeafblindUK have launched a new helpline for those living with User Syndrome.

Isabella Goldie @dbscotland said the helpline “provides a dedicated space where people can be understood, supported and empowered.”

Read more ➡️ https://t.co/9rlbuMuqqu

[The AOP @The_AOP]

⏰ Early Bird availability is ending soon for two of our standout 2026 events.

From Break to Brilliance - Early Bird closes tomorrow!

Locum Clinical Skills Conference - Early Bird closes on Saturday!

Visit the events section of the AOP website: https://t.co/Movc46RpnL

[@OptometryToday @OptometryToday]

We asked three contributors to The Myopia management and innovation edition, what invention would make the most difference to myopia management if it was to become commonplace in five years’ time?

Read what they had to say ➡️ https://t.co/KdnluUgI3a

[Solihull-LOC @Solihull_LOC]

Many thanks for your continued support and engagement from all of us at Solihull LOC!

We will be taking a well-earned break and will be returning to LOC work from 2nd January 2026.
We want to wish everyone who is celebrating a Merry Christmas, and to all a happy new year ahead

[@OptometryToday @OptometryToday]

The national negotiating body for eye care has described the outcome of GOS negotiations as “very disheartening”with the Department of Health and Social Care confirming a 2.5% increase in GOS1 fees.

Find out more here: https://t.co/ZBoBmF3VLD

[@OptometryToday @OptometryToday]

Richard Stead, consultant ophthalmologist and Newmedica glaucoma lead, shares insights for optometrists on drop-free cataract surgery.

Want to learn more about drop-free cataract surgery? Read here: https://t.co/GjhlBCzZod

[LOCSU @LOCSU]

Our latest newsletter including a review of our recent LOC development day is now available.

➡️ https://t.co/jtkBGj4GCU

#optometry #eyehealth #opticians #primarycare #newsletter #communication

[LOCSU @LOCSU]

Delegates can now book to take part in our latest LOC induction course, it’s due to begin on Monday 12 January 2026.

Read full details of this useful four-week course here https://t.co/6gazpF7s2W

#optometry #opticians #development

[LOCSU @LOCSU]

If you couldn’t make it to our LOC development day here’s what happened!

➡️ https://t.co/U0FFISB2Nr

#optometry #opticians #LOCSU #Development

[@OptometryToday @OptometryToday]

OFNC provides update on GOS fees and CPD grant.

The negotiating body for the optical sector has explained that the announcement of the 2025–2026 fees is delayed while further analysis is conducted.

Read more here: https://t.co/m2dJLmBWp3

[@OptometryToday @OptometryToday]

The @MHRAgovuk has approved Ryjunea for slowing myopia progression. It is the first time the MHRA has approved a low-dose atropine eye drop for myopia control.

Read more about this news ➡️ https://t.co/QoosEAcRxA